Therapeutic Asset Ratings

263 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Babaodan Hepatocellular Carcinoma	Nanfang Hospital, Southern Medical University	P4	B (56)
Sevoflurane Hepatocellular Carcinoma	Kaohsiung Medical University Chung-Ho Memorial Hospital	P4	B (56)
S-Ketamine Hepatocellular Carcinoma	The Second Affiliated Hospital of Chongqing Medical University	P4	B (56)
TENOFOVIR BIS(ISOPROPYLOXYCARBONYLOXYMETHYL) ESTER Hepatocellular Carcinoma	Qing XIe	P4	B (56)
FCH Hepatocellular Carcinoma	Queen's Medical Center	P3	B (56)
GENETICALLY-MODIFIED ONCOLYTIC TYPE 5 ADENOVIRUS WHICH SELECTIVELY REPLICATES IN TUMOR CELLS CONTAINING DYSFUNCTIONAL P53 GENE (H101) Hepatocellular Carcinoma	Fudan University	P3	B (56)
Letrozole Hepatocellular Carcinoma	Dan Zandberg	P3	B (56)
Metformin Hepatocellular Carcinoma	Dan Zandberg	P3	B (56)
Nanocrystalline Megestrol Acetate Suspension Hepatocellular Carcinoma	Nanfang Hospital, Southern Medical University	P3	B (56)
PREDNISONE TABLETS Hepatocellular Carcinoma	Pfizer	P3	B (56)
Rilvegostomig Hepatocellular Carcinoma	AstraZeneca	P3	B (56)
Tpst-1120 Hepatocellular Carcinoma	Tempest Therapeutics	P3	B (56)
Psma-Hbed-Cc Hepatocellular Carcinoma	Mayo Clinic	P2	B (56)
Envafolimab Hepatocellular Carcinoma	Anhui Provincial Hospital	P2	CCC (55)
Guadecitabine Hepatocellular Carcinoma	University of Southern California	P2	CCC (55)
Inkt Cells Hepatocellular Carcinoma	Beijing YouAn Hospital	P2	CCC (55)
Mtl-Cebpa Hepatocellular Carcinoma	Mina Alpha Limited	P2	CCC (55)
Palbociclib Hepatocellular Carcinoma	Henan Cancer Hospital	P2	CCC (55)
tenofovir Hepatocellular Carcinoma	Zhongshan Hospital (Xiamen), Fudan University	P3	CCC (54)
Zoledronate Hepatocellular Carcinoma	Sun Yat-sen University	P3	CCC (54)
Bavituximab Hepatocellular Carcinoma	University of Texas Southwestern Medical Center	P2	CCC (54)
Budigalimab Hepatocellular Carcinoma	AbbVie	P2/3	CCC (54)
gpc3-car-t cells Hepatocellular Carcinoma	RenJi Hospital	P1/2	CCC (53)
Acetylsalicylic Acid Hepatocellular Carcinoma	Yonsei University	P3	CCC (52)
ANTIBODY CS1003 Hepatocellular Carcinoma	CStone Pharmaceuticals	P3	CCC (52)

Showing 76 to 100 of 263 assets

PreviousPage 4 of 11Next